GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $287,000 | +12.1% | 6,549 | +11.3% | 0.01% | +30.0% |
| Q1 2022 | $256,000 | -1.2% | 5,883 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $259,000 | +11.6% | 5,883 | -3.3% | 0.01% | -30.8% |
| Q3 2021 | $232,000 | -0.9% | 6,083 | +3.4% | 0.01% | 0.0% |
| Q2 2021 | $234,000 | +11.4% | 5,883 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $210,000 | -2.8% | 5,883 | 0.0% | 0.01% | -7.1% |
| Q4 2020 | $216,000 | -4.0% | 5,883 | -1.7% | 0.01% | -17.6% |
| Q3 2020 | $225,000 | -4.7% | 5,983 | +3.5% | 0.02% | -15.0% |
| Q2 2020 | $236,000 | +7.8% | 5,783 | 0.0% | 0.02% | -13.0% |
| Q1 2020 | $219,000 | -19.5% | 5,783 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $272,000 | +10.1% | 5,783 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $247,000 | +6.9% | 5,783 | 0.0% | 0.02% | +9.5% |
| Q2 2019 | $231,000 | -5.3% | 5,783 | -4.9% | 0.02% | -16.0% |
| Q1 2019 | $244,000 | +10.4% | 6,083 | +5.2% | 0.02% | -10.7% |
| Q4 2018 | $221,000 | -9.4% | 5,783 | -4.9% | 0.03% | +12.0% |
| Q3 2018 | $244,000 | -0.4% | 6,083 | 0.0% | 0.02% | +13.6% |
| Q2 2018 | $245,000 | +3.4% | 6,083 | 0.0% | 0.02% | -18.5% |
| Q1 2018 | $237,000 | +8.2% | 6,083 | -1.5% | 0.03% | +12.5% |
| Q4 2017 | $219,000 | -12.0% | 6,177 | +1.5% | 0.02% | -17.2% |
| Q3 2017 | $249,000 | -5.0% | 6,083 | 0.0% | 0.03% | -3.3% |
| Q2 2017 | $262,000 | +2.7% | 6,083 | 0.0% | 0.03% | +11.1% |
| Q1 2017 | $255,000 | -1.5% | 6,083 | -9.4% | 0.03% | -10.0% |
| Q4 2016 | $259,000 | -1.9% | 6,717 | +10.2% | 0.03% | -6.2% |
| Q2 2016 | $264,000 | +6.9% | 6,096 | 0.0% | 0.03% | +3.2% |
| Q1 2016 | $247,000 | +0.4% | 6,096 | 0.0% | 0.03% | 0.0% |
| Q4 2015 | $246,000 | +6.0% | 6,096 | 0.0% | 0.03% | +3.3% |
| Q3 2015 | $232,000 | -8.7% | 6,096 | 0.0% | 0.03% | -3.2% |
| Q2 2015 | $254,000 | -9.6% | 6,096 | 0.0% | 0.03% | -8.8% |
| Q1 2015 | $281,000 | +7.7% | 6,096 | 0.0% | 0.03% | +9.7% |
| Q4 2014 | $261,000 | -24.3% | 6,096 | -18.7% | 0.03% | -24.4% |
| Q3 2014 | $345,000 | -14.0% | 7,496 | 0.0% | 0.04% | -16.3% |
| Q2 2014 | $401,000 | -73.1% | 7,496 | -73.1% | 0.05% | -73.4% |
| Q1 2014 | $1,490,000 | +0.1% | 27,896 | 0.0% | 0.18% | -5.2% |
| Q4 2013 | $1,489,000 | +6.4% | 27,896 | 0.0% | 0.19% | -0.5% |
| Q3 2013 | $1,400,000 | -13.3% | 27,896 | -13.6% | 0.20% | -16.7% |
| Q2 2013 | $1,614,000 | – | 32,296 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |